CEPHEID COVID-19 RSV INFLUENZA A/B PCR – Details

Influenza A PCR

Value   

Standard Range   

Negative

Negative

NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus (RSV) infection and should not be used as the sole basis for diagnosis,
treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results in asymptomatic individuals cannot be used as definite evidence that an
individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096 NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus
(RSV) infection and should not be used as the sole basis for diagnosis, treatment or other patient management
decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results
in asymptomatic individuals cannot be used as definite evidence that an individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096
NOTE:
This test has been authorized by the FDA on September 24,2020 for emergency use by authorized laboratories only for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV)
until emergency authorization is terminated or revoked.
Please refer to the following fact sheets for further information:
Fact Sheet for Healthcare providers – <https://www.fda.gov/media/142435/download>
Fact Sheet for Patients – <https://ww w.fda.gov/media/142436/download>
Testing performed on Cepheid Xp
ertXpress platform.

 

Influenza B PCR

Value   

Standard Range   

Negative

Negative

NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus (RSV) infection and should not be used as the sole basis for diagnosis,
treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results in asymptomatic individuals cannot be used as definite evidence that an
individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096 NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus
(RSV) infection and should not be used as the sole basis for diagnosis, treatment or other patient management
decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results
in asymptomatic individuals cannot be used as definite evidence that an individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096
NOTE:
This test has been authorized by the FDA on September 24,2020 for emergency use by authorized laboratories only for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV)
until emergency authorization is terminated or revoked.
Please refer to the following fact sheets for further information:
Fact Sheet for Healthcare providers – <https://www.fda.gov/media/142435/download>
Fact Sheet for Patients – <https://www.fda.gov/media/142436/download>
Testing performed on Cepheid Xp
ertXpress platform.

 

RSV

Value   

Standard Range   

Negative

Negative

NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus (RSV) infection and should not be used as the sole basis for diagnosis,
treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results in asymptomatic individuals cannot be used as definite evidence that an
individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096 NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus
(RSV) infection and should not be used as the sole basis for diagnosis, treatment or other patient management
decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results
in asymptomatic individuals cannot be used as definite evidence that an individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096
NOTE:
This test has been authorized by the FDA on September 24,2020 for emergency use by authorized laboratories only for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV)
until emergency authorization is terminated or revoked.
Please refer to the following fact sheets for further information:
Fact Sheet for Healthcare providers – <https://www.fda.gov/media/142435/download>
Fact Sheet for Patients – <https://www.fda.gov/media/142436/download>
Testing performed on Cepheid Xp
ertXpress platform.

 

SARS-CoV-2 PCR

Value   

Standard Range   

Negative

Negative

NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus (RSV) infection and should not be used as the sole basis for diagnosis,
treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results in asymptomatic individuals cannot be used as definite evidence that an
individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096 NEGATIVE results indicate that viral RNA was not detected. Negative results do not preclude SARS-CoV-2, influenza A virus, influenza B virus and/or respiratory syncytial virus
(RSV) infection and should not be used as the sole basis for diagnosis, treatment or other patient management
decisions. Negative results must be combined with clinical observations, patient history, and/or epidemiological information. Negative results
in asymptomatic individuals cannot be used as definite evidence that an individual has not been exposed to SARS-CoV-2, influenza viruses, or RSV and has not been infected with any of these viruses.

Specimen source is Nasopharyngeal Swab. Results from Accession 42-21-098-00096
NOTE:
This test has been authorized by the FDA on September 24,2020 for emergency use by authorized laboratories only for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV)
until emergency authorization is terminated or revoked.
Please refer to the following fact sheets for further information:
Fact Sheet for Healthcare providers – <https://www.fda.gov/media/142435/download>
Fact Sheet for Patients – <https://www.fda.gov/media/142436/download>
Testing performed on Cepheid Xp
ertXpress platform.
 

General Information

Ordered by Torian Easterling, MD

Carlos Alvarez, Collected on 05/19/2021 10:11 AM from Nasal (Nasopharyngeal Swab)

Resulted on 05/19/2021 12:45 PM

Result Status: Final result

This result was released by an automatic process. Your provider may not have reviewed this result yet. Please contact the ordering provider or your usual provider with any questions or concerns. When possible, we recommend using the Message My Doctor’s Office function in MyChart to contact your provider’s office.